Discontinuation report MYLAN-LOSARTAN
Report ID | 53729 |
Drug Identification Number | 02368277 |
Brand name | MYLAN-LOSARTAN |
Common or Proper name | LOSARTAN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BL, 100 BT |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-08-10 |
Actual discontinuation date | 2018-08-10 |
Remaining supply date | 2018-08-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Last lot 3078107 Expires 31-Dec-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-08-11 | English | Compare |
v7 | 2018-08-10 | French | Compare |
v6 | 2018-08-10 | English | Compare |
v5 | 2018-07-31 | French | Compare |
v4 | 2018-07-31 | English | Compare |
v3 | 2018-07-04 | English | Compare |
v2 | 2018-07-03 | French | Compare |
v1 | 2018-07-03 | English | Compare |
Showing 1 to 8 of 8